ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first ... such as Kaléo's AUVI-Q and Viatris' EpiPen – which dominates the market for emergency ...

MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the first quarter ended March 31, 2025. The Company ...

Resolution of CRL Manufacturing issues in progress - Type A meeting requested No clinical safety or efficacy concerns raised by FDA MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Miles ...

Shares of ARS Pharmaceuticals slipped after the biopharmaceutical company reported a first-quarter loss that was wider than analysts had expected. The stock was down 9%, to $12.12, in midday trading ...

And then as Frank mentioned, we’ll close with the Q&A. Turning to Slide 5 ... and we delivered life-saving NARCAN Nasal Spray across the U.S. and Canada to patients, customers and communities.

can be repeated at 1 h intervals (max 3 mg/24 h, 6 mg/week) Migranal® nasal spray 4 mg/ml nasal spray ... 80 mg tablets 160–240 mg q.d. divided b.i.d., t.i.d. or q.i.d. Propranolol ER ...

There are ways to reduce your chances of coming home from vacation with a terrible cold, digestive issues or other health problems.

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and re ...